Potential impact of drug-eluting stent in Sicilian clinical practice: Results of a multicentric "survey" and a cost-benefit analysis as compared to bare metal stents;Impatto potenziale dello stent medicato nella pratica clinica siciliana: Risultati di una "survey" multicentrica e di un'analisi costo-beneficio rispetto allo stent metallico

Italian Heart Journal, Supplementi

Volumn 5, Issue 8, 2004, Pages 630-638

  Gulizia, Michele ^a   Martelli, Elisa ^b   Tamburino, Corrado ^c   Tolaro, Salvatore ^d   Frasheri, Arian ^e   Giambanco, Francesco ^f   Grassi, Rosario ^g   Fiscella, Antonio ^h   Milazzo, Diego ⁱ  

^a San Luigi S Currò Hospital   (Italy)

^b Dipartimento di Economia Politica E Aziendale   (Italy)

^c Ospedale Ferrarotto   (Italy)

^d Centro Cuore Morgagni   (Italy)

^e Villa Maria Eleonora Hospital   (Italy)

^f Ospedale Civile Di Vicenza   (Italy)

^g Azienda Ospedaliera Papardo   (Italy)

^h CANNIZZARO HOSPITAL   (Italy)

ⁱ Azienda Ospedaliera San Giovanni di Dio   (Italy)

Author keywords

Cost benefit analysis; Costs; Drug eluting stents

Indexed keywords

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION TREE; DRUG DELIVERY SYSTEM; ECONOMICS; HUMAN; ITALY; MULTICENTER STUDY; QUESTIONNAIRE; RESTENOSIS; STATISTICAL MODEL; STENT;

CORONARY RESTENOSIS; COST-BENEFIT ANALYSIS; DECISION TREES; DRUG DELIVERY SYSTEMS; HUMANS; ITALY; LINEAR MODELS; QUESTIONNAIRES; STENTS;

EID: 21644456926     PISSN: 15903796     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. de Jaegere P, Serruys PW, Van Es GA, et al. Recoil following Wiktor stent implantation for restenotic lesions of coronary arteries. Cathet Cardiovasc Diagn 1994; 32: 147-56.
2. Serruys PW, Kiemeneij F, Macaya C, et al. A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. BENESTENT Study Group. N Engl J Med 1994; 331: 701-6.
3. Marx SO, Marks AR. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 2001; 87: 852-5,
4. Morice MC, Serruys PW, Sousa JE, et al, for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80.
5. Moses JW, Leon MB, Popma JJ, et al, for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-23.
6. Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus standard stent in patients at high risk for coronary restenosis. Circulation 2004; 109: 634-40.
7. Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med 1995; 332: 1004-14.
8. Grube E, Silber S, Hauptmann K, et al. TAXUS I: six and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003; 107: 38-42. (Pubitemid 36070930)
9. Tanabe K, Serruys PW, Grube E, et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003; 107: 559-64.
10. Stone GW, Ellis SG, Cox DA, et al, for the TAXUS IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-31.
11. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Metodi per la valutazione economica dei programmi sanitari. Roma: Il Pensiero Scientifico Editore, 2000.
12. Decreto 12-06-02 "Classificazione delle strutture sanitarie pubbliche e private e rideterminazione delle tariffe delle prestazioni di assistenza ospedaliera. Gazzetta Ufficiale della Regione Siciliana - Parte I, n. 30.
13. Cutlip DE, Chauhan MS, Baim DS, et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol 2002; 40: 2082-9.
14. Briguori C, Sarais C, Pagnotta P, et al. In stent restenosis in small coronary arteries: impact of strut thickness. J Am Coll Cardiol 2002; 40: 403-9.
15. Hausleiter J, Kastrati A, Mehilli J, et al. Predictive factors of early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. J Am Coll Cardiol 2002; 40: 882-9. (Pubitemid 34994981)
16. Pache J, Kastrati A, Mehilli J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR STEREO-2) trial. J Am Coll Cardiol 2003; 41: 1283-8. (Pubitemid 36438988)
17. Kastrati A, Dirschinger J, Boekstegers P, et al. Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1147 unselected patients. Catheter Cardiovasc Interv 2000; 50: 290-7. (Pubitemid 30439371)